Opinion

Video

Role of Pharmacists in Operationalizing Bispecific Antibodies

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Ke Ning, MD

Medical professionals highlight the essential support provided by pharmacists in addressing operational challenges related to bispecific antibodies. Pharmacists can play an important role in the development of policies and procedures, monitoring and management of toxicities, and delivery of educational resources.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
5 experts in this video
3 experts are featured in this series.
Related Content
Bispecific antibodies | Image Credit: © Galina - stock.adobe.com
January 16th 2025

Talquetamab and Teclistamab Achieve Deep, Durable Responses in Patients With Relapsed, Refractory Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition
April 17th 2023

Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

CAR T-cells targeting cancer cells | Image Credit: © furyon - stock.adobe.com
January 2nd 2025

Equecabtagene Autoleucel Shows Efficacy, Safety in Treatment of Patients With Heavily Pretreated Multiple Myeloma

Alexandra Gerlach, Associate Editor
Group of pharmacists -- Image credit: .shock | stock.adobe.com
December 27th 2024

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

Nicole Bentivegna, PharmD, BCOP Gabriela Aponte-Melendez, PharmD Natalie Kaufman, PharmD Cooper Bailey, PharmD
Multiple myeloma cells -- Image credit: Saiful52 | stock.adobe.com
December 26th 2024

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Amir Ali, PharmD, BCOP Kevin Le, PharmD, BCOP Tanjia Toma, PharmD Candidate Soumar Haddad, PharmD Candidate Fleuri Dindar, PharmD Candidate Bryan Ceballos, PharmD Candidate
Multiple myeloma under microscope -- Image credit: Saiful52 | stock.adobe.com
December 23rd 2024

Advancements in Multiple Myeloma Therapies and Operational Insights in Oncology Clinical Trials

Mike Hennessy Jr, President and CEO